University of Padua

AbbVie Launches PRODUODOPA® (foslevodopa/foscarbidopa) for People Living with Advanced Parkinson's Disease in the European Union

Retrieved on: 
Tuesday, January 9, 2024

NORTH CHICAGO, Ill., Jan. 9, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the launch of PRODUODOPA® (foslevodopa/foscarbidopa) in the European Union for the treatment of advanced Parkinson's disease with severe motor fluctuations and hyperkinesia (excessive movement) or dyskinesia (involuntary movement), and when available combinations of Parkinson's medicinal products have not given satisfactory results.1

Key Points: 
  • The VYAFUSER™ pump for the subcutaneous delivery of PRODUODOPA received Conformité Européenne (CE) Mark in November of 2023.
  • Parkinson's disease is a chronic, progressive neurodegenerative disorder affecting approximately 6.1 million people globally3 and is expected to double by 2040.
  • "This approval is an example of our unwavering commitment to this community by developing new, transformative therapeutic options for people experiencing advanced Parkinson's disease, their families, and care partners."
  • "It is vital that the Parkinson's community have more options that can help them manage their symptoms."

ICON's World Children's Day; access and inclusion for every child, upcoming Webinar Hosted by Xtalks

Retrieved on: 
Monday, October 30, 2023

TORONTO, Oct. 30, 2023 /PRNewswire-PRWeb/ -- ICON's Centre for Paediatric Clinical Development invites you to celebrate World Children's Day virtually with us on November 13, 2023. World Children's Day is recognised as an international coming together to advocate for, promote, and celebrate the rights and welfare of children and create dialogue and action plans to build a better world for children. First established in 1954, it also commemorates the day when the UN General Assembly adopted the Declaration of the Rights of the Child in 1959 and when the UN General Assembly adopted the Convention on the Rights of the Child in 1989.

Key Points: 
  • Attendees will learn about increasing awareness of the needs and effort behind providing access to safe and accurate dosage forms of medicines for every child.
  • The featured speakers will discuss how drug development can be expedited for children and their families to provide access to adapted medicines and innovative medicines.
  • TORONTO, Oct. 30, 2023 /PRNewswire-PRWeb/ -- ICON's Centre for Paediatric Clinical Development invites you to celebrate World Children's Day virtually with us on November 13, 2023.
  • For more information, or to register for this event, visit ICON's World Children's Day .

FICO Awards Research Team for Innovative Work in Climate-Aware Power Optimization

Retrieved on: 
Thursday, August 3, 2023

Analytics software leader FICO has awarded a prize to a research team for exceptional research in mathematical optimization and operations research.

Key Points: 
  • Analytics software leader FICO has awarded a prize to a research team for exceptional research in mathematical optimization and operations research.
  • The winning paper, “Climate‐aware generation and transmission expansion planning: A three‐stage robust optimization approach” was published in European Journal of Operational Research, vol.
  • More information on both papers is available in blog posts on the Optimization Blog , part of FICO® Xpress Optimization Community.
  • FICO® Xpress Optimization allows businesses to easily build, deploy and use optimization solutions that crunch through millions of potential scenarios to find the ideal solution.

Robert S. Ruffini Innovation and Entrepreneurship Award

Retrieved on: 
Tuesday, July 11, 2023

The event was attended by delegates from around the world, who shared presentations on the latest advances in the field.

Key Points: 
  • The event was attended by delegates from around the world, who shared presentations on the latest advances in the field.
  • With a focus on innovation and collaboration, the conference was a great success, showcasing the latest research and developments in this area of induction heating technology.
  • This year, HES-23 and Fluxtrol Inc. have partnered to provide a competition-based award and recognition program, aptly named the ROBERT S. RUFFINI INNOVATION AND ENTREPRENEURSHIP AWARD, for aspiring young innovators and professionals.
  • The esteemed award was presented to the winner Mikus Milgrāvis for his project and demonstration of a crucible stirrer.

Octapharma Puts a Spotlight on the Infection Burden in Patients With Chronic Lymphocytic Leukaemia (CLL) at the European Hematology Association (EHA) Hybrid Congress 2023

Retrieved on: 
Wednesday, June 7, 2023

Secondary immunodeficiency (SID) is a common complication in patients with haematological malignancies such as CLL.

Key Points: 
  • Secondary immunodeficiency (SID) is a common complication in patients with haematological malignancies such as CLL.
  • Finally, Professor Livio Trentin, University of Padua, Italy, will speak about his experience using subcutaneous immunoglobulin therapy for infection prophylaxis in patients with CLL.
  • Stephan Stilgenbauer, Professor of Medicine and Medical Director of the Comprehensive Cancer Centre in Ulm, Germany, will chair the session.
  • The results of this analysis on 3,846 SID patients will be displayed and commented during the poster session of the Congress on June 9, 2023:

ALVISE GIUSTINIANI JOINS WISEKEY’S ADVISORY BOARD

Retrieved on: 
Wednesday, April 12, 2023

Geneva, Switzerland – April 12, 2023: WISeKey International Holding Ltd. (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a leading global cybersecurity, AI and IoT company, is pleased to welcome Alvise Giustiniani to its advisory board.

Key Points: 
  • Geneva, Switzerland – April 12, 2023: WISeKey International Holding Ltd. (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a leading global cybersecurity, AI and IoT company, is pleased to welcome Alvise Giustiniani to its advisory board.
  • Mr. Giustiniani brings with him over 30 years of executive leadership experience from Philip Morris International (PMI), where he served in various top positions.
  • "Alvise brings a wealth of experience and strategic wisdom to our Advisory Board," said Carlos Moreira, Founder and CEO of WISeKey.
  • "I am honoured to join WISeKey's Advisory Board and look forward to contributing to the Company's mission of securing the Internet of Things and fight counterfeits," said Mr. Giustiniani.

Tyvak International Vice President of Programs Margherita Cardi to Present at University of Padova 800th Anniversary Celebration

Retrieved on: 
Friday, September 30, 2022

Tyvak International SRL, a leading European nano and microsatellite provider based in Torino, Italy, today announced its participation in the University of Padovas 800th Anniversary Celebration on Saturday, October 1 at 5:00 p.m. CEST.

Key Points: 
  • Tyvak International SRL, a leading European nano and microsatellite provider based in Torino, Italy, today announced its participation in the University of Padovas 800th Anniversary Celebration on Saturday, October 1 at 5:00 p.m. CEST.
  • As part of the celebration, Tyvak Internationals Vice President of Programs and Program Manager for the Hera Milani satellite, Margherita Cardi, will present on the NASA and ESA Join Forces to Defend Earth from Asteroids: The DART and Hera Missions panel.
  • View the full release here: https://www.businesswire.com/news/home/20220930005407/en/
    The presentation will delve into the value and implications of the Hera Milani mission.
  • Tyvak International SRL, a subsidiary of Terran Orbital Corporation, is a leading European nano and microsatellite provider, based in Torino, Italy.

Maschio Uncorks U.S. Retail Market With Campaign That Puts Consumers Front And Center

Retrieved on: 
Wednesday, August 10, 2022

VISNÀ DI VAZZOLA, Italy,  August 10, 2022 /PRNewswire-PRWeb/ -- Cantine Maschio, makers of premium DOC-quality Proseccos beloved globally, is targeting the U.S. retail market in a major way with a new celebratory, feel-good campaign that puts the consumer first.

Key Points: 
  • Featuring the theme "No End to The Weekend", the campaign positions Maschio as the perfect all-occasion Prosecco, offering a bevy of cocktail recipes and entertainment ideas and easy-to-digest product information.
  • Maschio will also unveil an exciting new look designed with retail customers in mind.
  • "Maschio is already our top Prosecco brand in the U.S. thanks to the tremendous reception by restaurants around the country.
  • Its story began when founder Bonventura Maschio converted a distillery into a state-of-the-art winery in 1973.

Navitas Highlights Next-Gen Power IC Technology at Prestigious ‘GaN Marathon’ Workshop

Retrieved on: 
Monday, June 13, 2022

GaN is a next-generation power semiconductor technology running 20 times faster than traditional silicon.

Key Points: 
  • GaN is a next-generation power semiconductor technology running 20 times faster than traditional silicon.
  • Navitas Matteo Uccelli will present a technical paper entitled Evolution in GaN Power IC Integration: Loss-less Sensing and Autonomous Protection, which introduces the latest developments in GaNFast ICs with GaNSense technology, and leading-edge applications.
  • The GaN Marathon has become an important event for the GaN community and we are happy to participate in the sold-out 2022 workshop, says Dan Kinzer, Navitas COO/CTO and co-founder.
  • GaN power ICs integrate GaN power with drive, control, protection and sensing to enable faster charging, higher power density and greater energy savings for mobile, consumer, enterprise, eMobility and new-energy markets.

GLOBAL CONFERENCE ON PEDIATRIC PALLIATIVE CARE IN ROME SUPPORTED BY THE FONDAZIONE MARUZZA LEFEBVRE

Retrieved on: 
Wednesday, May 25, 2022

ROME, May 25, 2022 /PRNewswire/ -- The Eternal City is ready to host the leading international pediatric palliative care specialists from May 25 to 29. Two years after the pandemic, the Maruzza Lefebvre Foundation is organizing the "5th International Maruzza Congress on Paediatric Palliative Care" (https://www.childrenpalliativecarecongress.org/congress-2022/), an international event that brings together health professionals from all over the world, engaged in assisting minors suffering from incurable diseases of high and medium care complexity. The three-day conference is dedicated to scientific research, training and exchange of knowledge with a distinct purpose: to provide doctors and nurses the most recent updates, in order for them to deliver the best possible care to children and families living with a diagnosis of incurability.

Key Points: 
  • There are 22 million infants, children and adolescents worldwide who are affected by incurable diseases and would benefit from pediatric palliative care.
  • Since 1999 the Foundation has been involved in the field of pain therapy and pediatric palliative care for minors suffering from incurable diseases.
  • Today the Maruzza Foundation is a leading national and international organization in the field of Palliative Care.
  • For further information www.fondazionemaruzza.org
    International Standards for Pediatric Palliative Care: From IMPaCCT to GO-PPaCS https://www.sciencedirect.com/science/article/pii/S0885392421007119 Benini et al - Volume 63, Issue 5, May 2022, Pages e529-e543